Profound thrombocytopenia in previously treated patients with recurrent ovarian carcinoma receiving topotecan

Gynecol Oncol. 1998 May;69(2):175-8. doi: 10.1006/gyno.1998.4966.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Carcinoma / drug therapy*
  • Drug Administration Schedule
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Ovarian Neoplasms / drug therapy*
  • Platelet Count
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / complications
  • Topotecan / administration & dosage
  • Topotecan / adverse effects*
  • Topotecan / therapeutic use

Substances

  • Antineoplastic Agents
  • Topotecan